Blackstone invests $2 billion in Alnylam, boosting gene-silencing drug development [Yahoo! Finance News]
Blackstone Inc. (BX)
Last blackstone inc. earnings: 4/23 06:56 am
Check Earnings Report
US:NYSE Investor Relations:
ir.blackstone.com/investors/shareholders/default.aspx
Company Research
Source: Yahoo! Finance News
Reuters) - Blackstone Group Inc said on Monday it invested $2 billion in Alnylam Pharmaceuticals Inc through an equity-and-debt deal, giving the drugmaker a financial boost to develop its gene-silencing therapies.Alnylam, whose shares were nearly 7% higher in premarket trading, specializes in the development of medicines using the Nobel prize-winning RNA interference RNAi) technology and earlier this month agreed to develop treatments for the new coronavirus with Vir Biotechnology Inc .Blackstone said on Monday it purchased 50% of the royalties on global sales of Alnylam's cholesterol therapy inclisiran, currently under review by the U.S. Food and Drug Administration.Inclisiran, belonging to a class of drugs that inhibit a protein known as PCSK9, was co-developed with The Medicines Co, which was bought by Novartis AG earlier this year.The private equity firm said it would provide $1 billion in committed payments to Alnylam, a term loan of up to $750 million, and purchase $100 milli
Show less
Read more
Impact Snapshot
Event Time:
BX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BX alerts
High impacting Blackstone Inc. news events
Weekly update
A roundup of the hottest topics
BX
News
- Blackstone Taps Dealmakers From KKR, Ares in Private Credit Push [Yahoo! Finance]Yahoo! Finance
- Blackstone Inc. (NYSE: BX) had its price target raised by analysts at Keefe, Bruyette & Woods from $169.00 to $175.00. They now have a "market perform" rating on the stock.MarketBeat
- Apollo Says Private Credit May Reach $40 Trillion by 2030 [Yahoo! Finance Canada]Yahoo! Finance Canada
- Apollo Says Private Credit Is Already Half Way to $40 Trillion [Yahoo! Finance]Yahoo! Finance
- Blackstone Inc. (NYSE: BX) had its price target raised by analysts at BMO Capital Markets from $134.00 to $157.00. They now have a "market perform" rating on the stock.MarketBeat
BX
Earnings
- 10/17/24 - Beat
BX
Sec Filings
- 12/20/24 - Form 4
- 12/13/24 - Form 4
- 12/6/24 - Form 8-K
- BX's page on the SEC website